Ian (Hrsg.) Olver

The MASCC Textbook of Cancer Supportive Care and Survivorship

Buch

This book is intended for medical students, residents, and fellows, as well as medical oncologists, radiation oncologists, surgeons, general practitioners, nurses and allied health workers. Complete with case vignettes, key points, and sidebar summaries to further assist readers using practical tips and tricks, this textbook provides current information on the management and prevention of cancer-related side effects, referring to up-to-date sources that are useful for conducting further research. It also introduces new topics, such as financial toxicity and complementary medicine, as well as covering the new side effects of targeted therapies… Mehr

CHF 165.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

V105: Folgt in ca. 15 Arbeitstagen

Produktdetails

ISBN: 978-3-030-08150-8
EAN: 9783030081508
Produktnummer: 37966270
Verlag: Springer International Publishing
Sprache: Englisch
Erscheinungsjahr: 2019
Seitenangabe: 736 S.
Masse: H25.4 cm x B17.8 cm x D3.6 cm 1'547 g
Auflage: Softcover reprint of the original 2nd ed. 2018
Abbildungen: Paperback
Gewicht: 1547

Über den Autor

Ian Olver, MD, PhD is CEO, Cancer Council Australia, a Clinical Professor in the Department of Medicine at the University of Sydney and is an Honorary Associate, Department of Medical Oncology, Royal Prince Alfred Hospital. He has published over 180 articles in journals, 16 book chapters and 2 books: Conquering Cancer. Your Guide to Treatment and Research, and Is Death Ever Preferable to Life? and co-edited When Cancer Crosses Disciplines: A Physicians Handbook. After serving on several ethics committees in Victoria and South Australia and the American Society of Clinical Oncology (ASCO) Ethics Committee, and chairing the Cancer Institute NSW Research Ethics Committee for multi-centre cancer trials, he now sits on the Australian Health Ethics Committee of the NHMRC and chairs the Medical Oncology Group of Australia Ethics Committee. He previously served on The Australian Drug Evaluation Committee (ADEC) and the Cancer Strategies Group of the Australian Government and chaired the Medical Oncology Group of Australia (MOGA). He now serves on the Board of the National Breast and Ovarian Cancer Centre, the executive of the Clinical Oncological Society of Australia and the Advisory Board of Cancer Australia and the Community and Preventative Health Committee of NH+MRC.